KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Investing Activities (2016 - 2025)

Astrana Health's Cash from Investing Activities history spans 16 years, with the latest figure at -$534.5 million for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 6492.71% year-over-year to -$534.5 million; the TTM value through Sep 2025 reached -$571.3 million, down 235.06%, while the annual FY2024 figure was -$192.4 million, 193.63% down from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$534.5 million at Astrana Health, down from -$1.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $39.1 million in Q4 2021 and bottomed at -$534.5 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is -$10.5 million (2021), against an average of -$41.4 million.
  • The largest annual shift saw Cash from Investing Activities surged 173.38% in 2021 before it plummeted 6492.71% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $39.1 million in 2021, then crashed by 66.22% to $13.2 million in 2022, then crashed by 186.56% to -$11.4 million in 2023, then tumbled by 191.63% to -$33.3 million in 2024, then plummeted by 1503.86% to -$534.5 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Cash from Investing Activities are -$534.5 million (Q3 2025), -$1.1 million (Q2 2025), and -$2.4 million (Q1 2025).